Application 209938

Type
ANDA
Sponsor
TEVA PHARMS USA INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ELTROMBOPAGELTROMBOPAGTABLET;ORAL12.5MGNoNo
002ELTROMBOPAGELTROMBOPAGTABLET;ORAL25MGNoNo
003ELTROMBOPAGELTROMBOPAGTABLET;ORAL75MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A209938-001ELTROMBOPAG OLAMINEELTROMBOPAG OLAMINEEQ 12.5MG ACIDTABLET / ORALAB2026-07-13
A209938-002ELTROMBOPAG OLAMINEELTROMBOPAG OLAMINEEQ 25MG ACIDTABLET / ORALAB2026-07-13
A209938-003ELTROMBOPAG OLAMINEELTROMBOPAG OLAMINEEQ 75MG ACIDTABLET / ORALAB2026-07-13

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A209938-001AB
A209938-002AB
A209938-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A209938-001ELTROMBOPAG OLAMINEEQ 12.5MG ACIDTABLET / ORALAB2026-07-13d4dbc9d85df4…
2026-11-14 07:37:172026-10A209938-002ELTROMBOPAG OLAMINEEQ 25MG ACIDTABLET / ORALAB2026-07-13d4dbc9d85df4…
2026-11-14 07:37:172026-10A209938-003ELTROMBOPAG OLAMINEEQ 75MG ACIDTABLET / ORALAB2026-07-13d4dbc9d85df4…
2026-10-15 13:18:302026-09A209938-001ELTROMBOPAG OLAMINEEQ 12.5MG ACIDTABLET / ORALAB2026-07-13c2088c7a36db…
2026-10-15 13:18:302026-09A209938-002ELTROMBOPAG OLAMINEEQ 25MG ACIDTABLET / ORALAB2026-07-13c2088c7a36db…
2026-10-15 13:18:302026-09A209938-003ELTROMBOPAG OLAMINEEQ 75MG ACIDTABLET / ORALAB2026-07-13c2088c7a36db…
2026-09-14 22:38:342026-08A209938-001ELTROMBOPAG OLAMINEEQ 12.5MG ACIDTABLET / ORALAB2026-07-1384e616aacf4f…
2026-09-14 22:38:342026-08A209938-002ELTROMBOPAG OLAMINEEQ 25MG ACIDTABLET / ORALAB2026-07-1384e616aacf4f…
2026-09-14 22:38:342026-08A209938-003ELTROMBOPAG OLAMINEEQ 75MG ACIDTABLET / ORALAB2026-07-1384e616aacf4f…
2026-08-18 06:07:402026-07A209938-001ELTROMBOPAG OLAMINEEQ 12.5MG ACIDTABLET / ORALAB2026-07-13caaa826d4ba7…
2026-08-18 06:07:402026-07A209938-002ELTROMBOPAG OLAMINEEQ 25MG ACIDTABLET / ORALAB2026-07-13caaa826d4ba7…
2026-08-18 06:07:402026-07A209938-003ELTROMBOPAG OLAMINEEQ 75MG ACIDTABLET / ORALAB2026-07-13caaa826d4ba7…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A209938-001AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A209938-002AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A209938-003AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09A209938-001AB1c2088c7a36db…
2026-10-15 13:18:302026-09A209938-002AB1c2088c7a36db…
2026-10-15 13:18:302026-09A209938-003AB1c2088c7a36db…
2026-09-14 22:38:342026-08A209938-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A209938-002AB184e616aacf4f…
2026-09-14 22:38:342026-08A209938-003AB184e616aacf4f…
2026-08-18 06:07:402026-07A209938-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A209938-002AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A209938-003AB1caaa826d4ba7…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EltrombopagELTROMBOPAGTeva Pharmaceuticals, Inc.42ad8f58-bd6c-4f0e-9017-f2da2893fcae2025-12-15Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 209938
application number: ANDA209938

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.